Trial Profile
Phase 2b trial of varlitinib in patients with gastric cancer
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 26 May 2015
Price :
$35
*
At a glance
- Drugs Varlitinib (Primary)
- Indications Gastric cancer; Solid tumours
- Focus Therapeutic Use
- Sponsors ASLAN Pharmaceuticals
- 09 Aug 2013 New trial record